CHINA PHARMA HOLDINGS, INC. (CPHI)

Every figure this model derived for CPHI, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 59,324 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 304,874 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,006,618 AssetsCurrent 2026-06-30
current liabilities 7,681,602 LiabilitiesCurrent 2026-06-30
equity 36,181,280 StockholdersEquity 2026-06-30
interest expense 32,068 InterestExpense 2026-06-30
ocf -140,490 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,914,090 Revenues 2026-06-30
sbc 0 AllocatedShareBasedCompensationExpense 2024-09-30

The ratios

The figures themselves rather than their scores — what somebody looking up CPHI on one particular measure came for.

RatioValue
cash operating margin-98.46
current ratio0.27
current ratio reported0.26
deferred revenue growth97.78
dilution pct145.89
ev owner earnings-192.04
ev sales9.8
fcf margin-5.1
interest cover-136.51
operating margin-111.84
owner earnings margin-5.1
revenue growth-10.97
revenue growth per share-63.79
roic-9.64
rule of 40-122.8
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about CPHI's figures. Written by the derivation as it ran, not added afterwards.